Electrophoresis - Market Insights, Competitive Landscape, and Market Forecast - 2030

Electrophoresis Market By Type (DNA Electrophoresis, RNA Electrophoresis, And Protein Electrophoresis), By Product (Gel Electrophoresis, Capillary Electrophoresis, Reagents & Consumables, And Others), By Application (Diagnosis, Research & Development, Quality Control & Process Validation, And Others), By End-User (Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Hospitals & Diagnostic Laboratories, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2027 owing to the increasing prevalence of various cancer, infectious, and genetic disorder and surging number of industry-academia research collaboration for research & developmental activities.

The global electrophoresis market is estimated to grow at a CAGR of 5.83% during the forecast period from 2022 to 2027. The electrophoresis market is observing substantial market growth due to the growing prevalence of cancers, infectious, and genetic diseases such as lung cancer, colon cancer, rheumatoid arthritis, multiple myeloma, chronic lymphocytic leukemia, cystic fibrosis, Huntington's disease, alpha thalassemia, and others. Electrophoresis is used for the detection of the aforementioned diseases, therefore the increasing prevalence of these diseases will increase the demand for electrophoresis in the upcoming years. Furthermore, the surging number of industry-academia research collaborations for R&D activities, the increasing use of next-generation sequencing and capillary electrophoresis with mass spectroscopy for diagnosis of various chronic diseases, the increasing approval activities by regulatory authorities for devices, reagents, and software, and the presence of key players in the market will create a requisite for electrophoresis in the market. Therefore, the electrophoresis market is estimated to grow at a substantial CAGR during the forecast period from 2022 to 2027.

Electrophoresis Market Dynamics:

One of the key aspects for driving the electrophoresis market is the rising burden of various cancers, infectious, and genetic diseases across the globe.

According to the World Health Organization (WHO) 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The new cases of breast cancer in 2020 were 2.26 million cases, across the globe. The same source stated that lung cancer accounted for 2.21 million new cases, colon and rectum cancer for 1.93 million new cases, prostate cancer with 1.41 million new cases, skin cancer accounted for 1.20 million new cases, and stomach cancer was 1.09 million, 2020, globally.

Additionally, according to the latest data provided by UNAIDS, nearly 37.7 million people globally were living with HIV in 2020, and 1.5 million people became newly infected with HIV in 2020.

Thus, the increasing prevalence of cancer and infectious ailments across the globe will increase the demand for electrophoresis as these devices are used for the diagnosis of the afore-said diseases.

Additionally, the increasing use of next-generation sequencing and capillary electrophoresis with mass spectroscopy for the diagnosis of various chronic diseases and research & developmental activities will lead to an increased demand for electrophoresis. High-throughput proteomics technologies combined with advanced bioinformatics are extensively used to identify molecular signatures of diseases based on protein pathways and signaling cascades. Mass spectrometry plays a vital role in proteomics and has become an indispensable tool in molecular and cellular biology.

Furthermore, surging product approvals across the globe will in turn increase the demand for electrophoresis during the forecast period. For instance, in May 2019, the US FDA issued clearance for HYDRASYS 2, which is developed by Sebia, Inc., which is a leading provider of clinical protein electrophoresis equipment and reagents used for various disease screening and monitoring. HYDRASYS 2 is an all-in-one gel electrophoresis system with perforce staining, scanning, and migration.

Therefore, the factors stated above collectively will drive the overall Electrophoresis market throughout the forecast period from 2022-2027.

However, the time-consuming process, the presence of alternative techniques, and others may halt the market growth of electrophoresis.

The electrophoresis market was positively impacted during the period of COVID- 19 pandemic. During the initial stage of the pandemic, the sale of electrophoresis suffered collapse owing to the imposition of strict lockdown rules, disruption in manufacturing, and supply. However, the electrophoresis technique was used in the development of the Covid-19 vaccine. For instance, in July 2022, Elsan conducted a clinical trial to assess serum inflammation profiles by protein electrophoresis, a type of electrophoresis technique on patients hospitalized for infection due to the SARS-CoV-2 virus. On the other hand, gel electrophoresis, a type of electrophoresis was even used for the detection of the Covid-19 virus. Thus, as the number of cases of covid-19 increases, the demand for electrophoresis rises drastically. Likewise, the ease of lockdown restrictions, the upturn of resources and supply chain, the administration of a vaccine to the public, and with the increasing demand of electrophoresis for detection and research purposes, the demand for electrophoresis increases and is anticipated to do the same during the forecast period from 2022 - 2027.

Electrophoresis Market Segment Analysis:

Electrophoresis Market by Type (DNA Electrophoresis, RNA Electrophoresis, and Protein Electrophoresis), Product (Gel Electrophoresis, Capillary Electrophoresis, Reagents & Consumables, and Others), Application (Diagnosis, Research & Development, Quality Control & Process Validation, and Others), End-User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the electrophoresis market, the gel electrophoresis segment is expected to have a significant revenue share in the year 2021. This was primarily owing to the low operating and instrument costs, rising applications in the pharmaceutical and biotechnology industries, and the increasing burden of infectious diseases, cancer, and genetic disorders.

Also, the expanding launches and strategic investments, and other activities by the key players related to the segment will support driving its market during the forecast period.

The gel electrophoresis technique is used to identify many proteins that are significant for improved characterization of tumor progression and molecular specificity of both lung cancer subtypes. As a result of gel electrophoresis, it is possible to distinguish proteins from tumor cells, which aids in tumor diagnosis and may contribute to the segment's growth.

Further, various strategic steps taken by the key players in the market will help in increasing the demand for gel electrophoresis. For instance, in September 2020, miniPCR bio launched GELATO, a gel electrophoresis system with an integrated blue light with transillumination technology, allowing simultaneous nucleic acid separation.

Therefore, owing to the above-mentioned factors, the demand for gel electrophoresis upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global electrophoresis market during the forecast period.

North America is expected to dominate the overall Electrophoresis Market:

Among all the regions, North America is expected to dominate the global electrophoresis in the year 2021 and is expected to do the same during the forecast period from 2022-2027.

This can be ascribed to the increasing demand for electrophoresis in the region owing to the increasing number of genomic research projects, the growing prevalence of chronic diseases; collaborations between industry and academia, surging product approvals and launches, and others are among the key factors that contribute to the growth of the electrophoresis market in North America during the forecast period from 2022 - 2027.

For instance, according to GLOBOCAN 2021, the total number of new cancer cases was 2,281,658 in the United States, in 2020. The rising cases of cancers will increase the demand for electrophoresis as these devices are used for the detection of tumors in a sample.

Further, the pharmaceutical and biopharmaceutical industries in the region are increasing R&D investment. For instance, according to the Pharmaceutical Research and Manufacturers of America (PhRMA), the biopharmaceutical industry in the United States is one of the top world leaders in new drug development. In 2020, the entire biopharmaceutical and pharmaceutical industry invested an estimated USD 91.1 billion in research and development (R&D), up from approximately USD 83 billion in 2019. It is expected that research and development activity will increase in the same manner during the forecast period, ultimately increasing the demand for electrophoresis reagents and devices, thereby surging overall market growth of electrophoresis.

Moreover, the market players are continuously concentrating on the development of advanced electrophoresis devices and reagents, and this is likely to drive the market in the region. For instance, in September 2021, a novel capillary electrophoresis system, BioPhase8800, was introduced by Sciex Company for biological characterization during biopharmaceutical therapy. The new device analyzes eight samples simultaneously and is a multi-capillary system for capillary electrophoresis sodium dodecyl sulfate (CE-SDS).

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the electrophoresis market.

Electrophoresis Market Key Players:

Some of the key market players operating in the electrophoresis market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Agilent Technologies, Danaher., Merck KGaA, PerkinElmer Inc., Hoefer Inc., QIAGEN, Lonza Group Ltd., Shimadzu Corporation., Harvard Bioscience, CBS Scientific., Lumex Instruments, Cleaver Scientific, Sebia, Synoptics Ltd, ACTGene Inc., Analytik Jena GmbH, Cytiva, and others.

Recent Developmental Activities in the Electrophoresis Market:

• In September 2022, miniPCR bio, a developer of scientific equipment for researchers, unveiled the BanditTM STEM Electrophoresis Kit, an educational electrophoresis device. Bandit is a low-cost STEM activity kit that allows kids to build and operate a functioning gel electrophoresis device.
• In August 2022, Amerigo Scientific, a distributor focused on supplying products and services to the biomedical and life science communities, announced the release of their new CALX8 Reagent for life science laboratory scientists. This reagent is extensively used in molecular biology research, such as cell lysis, protein purification, electrophoresis, and immunoassays.
• In September 2020, Hitachi High-Tech Corporation, based in Japan, launched a Hitachi DS3000 compact capillary electrophoresis (CE) sequencer in collaboration with Promega Corporation, based in the United States. The Hitachi DS3000 is an easy-to-use, portable CE sequencer that can be used for verifying significant amounts of gene-sequence data that have been analyzed by next-generation sequencers and carrying out fragment analysis used in human identification.

Key Takeaways from the Electrophoresis Market Report Study

• Market size analysis for current electrophoresis market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the electrophoresis market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global electrophoresis market.
• Various opportunities available for the other competitor in the electrophoresis market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027.
• Which are the top-performing regions and countries in the current electrophoresis market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for electrophoresis market growth in the coming future?

Target Audience who can be benefited from this Electrophoresis Market Report Study

• Electrophoresis providers
• Research organizations and consulting companies
• Electrophoresis-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in electrophoresis
• Various end users who want to know more about the electrophoresis market and the latest developments in the electrophoresis market.

Frequently Asked Questions for the Electrophoresis Market:

1. What is Electrophoresis?
Electrophoresis is a procedure to separate and/or purify the molecules like nucleic acids and proteins, under the influence of electricity. It is one of the most conventional techniques used in biotechnology, which separates the particles based on the charge and size they possess. This technology can be used for the diagnosis of various diseases, DNA sequencing, analysis of antibodies and steroids, and other medical research activities.

2. What is the global market for electrophoresis?
The global electrophoresis market is estimated to grow at a CAGR of 5.83% during the forecast period from 2022 to 2027.

3. What are the drivers for the global electrophoresis market?
The electrophoresis market is witnessing positive market growth owing to the factors such as growing incidence of cancer, infectious disease, and genetic disorder, surging number of industry-academia research collaborations for R&D, increasing use of next-generation sequencing and capillary electrophoresis with mass spectroscopy for diagnosis, increasing approval activities by regulatory authorities for devices, reagent, and software, surging new devices launches, presence of key players in the market, and others will create an exigency for the electrophoresis market.

4. Who are the key players operating in the global electrophoresis market?
Some of the key market players operating in the electrophoresis market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Agilent Technologies, Danaher., Merck KGaA, PerkinElmer Inc., Hoefer Inc., QIAGEN, Lonza Group Ltd., Shimadzu Corporation., Harvard Bioscience, CBS Scientific., Lumex Instruments, Cleaver Scientific, Sebia, Synoptics Ltd, ACTGene Inc., Analytik Jena GmbH, Cytiva, and others.

5. Which region has the highest share of the electrophoresis market?
Among all the regions, North America is estimated to hold a significant revenue share in the global electrophoresis market. This can be ascribed to the increasing demand for electrophoresis among the patients in the region owing to the increasing prevalence of various cancers, infectious, and genetic disorders. Further, the rising burden of geriatric patients prone to chronic diseases, increasing use of next-generation sequencing and capillary electrophoresis with mass spectroscopy for diagnosis, and the presence of key domicile players in the region are the reasons which act as a supportive factor for the North America Electrophoresis market growth.


This product will be delivered within 2 business days.